# OnCo record nct05586074 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05586074/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05586074", "NCT05586074" ;
  schema:name "HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML"@en ;
  schema:description "A phase 3 trial testing Clifutinib in acute myeloid leukaemia, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05586074/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05586074> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2023-03-03" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/aml-flt3/> ;
  onco:drugs <https://onco.cc/drugs/clifutinib/> ;
  onco:companies <https://onco.cc/companies/sunshine-lake-pharma/> .